A detailed history of Vawter Financial, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Vawter Financial, Ltd. holds 1,861 shares of LLY stock, worth $1.48 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
1,861
Previous 1,761 5.68%
Holding current value
$1.48 Million
Previous $1.59 Billion 3.41%
% of portfolio
1.01%
Previous 1.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $77,214 - $96,002
100 Added 5.68%
1,861 $1.65 Billion
Q2 2024

Aug 02, 2024

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 0.57%
1,761 $1.59 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $15,989 - $21,391
27 Added 1.57%
1,751 $1.36 Billion
Q3 2023

Dec 20, 2023

BUY
$434.7 - $599.3 $749,422 - $1.03 Million
1,724 New
1,724 $926 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $604,675 - $808,521
1,724 New
1,724 $809 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vawter Financial, Ltd. Portfolio

Follow Vawter Financial, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vawter Financial, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vawter Financial, Ltd. with notifications on news.